Jeff Hester PhD

Jeff Hester, PhD has worked in the scientific field since 2001. Jeff began their career at IBT Laboratories as the Associate Director of Research. In 2006, they moved to the University of Kansas Medical Center, where they served as the Director of Molecular Diagnostics until 2007. Jeff then joined Viracor Eurofins Laboratories as the VP of Research and Development until 2021. In 2021, they moved to KCAS Bioanalytical & Biomarker Services as the Senior Director, Cell and Gene Therapy. Most recently, in 2022, they began working as the Chief Scientific Officer at PathologyWatch.

Jeff Hester, PhD obtained a B.S. in Chemistry from the University of Cincinnati in 1995. Jeff then continued their studies at the University of Cincinnati and obtained a Ph.D. in Chemistry/Biochemistry in 2003.